New advances in artificial intelligence (AI) could streamline the process of diagnosing breast cancer. Traditional methods of mitotic counting, which assess cellular division, can be inefficient and prone to errors. With AI, this process can be standardized, reducing variability and inconsistency. However, effective implementation of these AI tools requires high-quality, diverse training data, ongoing validation, and direct feedback from pathologists. Despite the challenges, AI integration presents a promising future for breast cancer diagnostics and the broader spectrum of medical diagnostics.
New Triada comes preinstalled on Android devices
A new variant of the Triada Trojan has been discovered pre-installed on Android devices, enabling data theft from the moment the device is set up,
